Severe renal failure and microangiopathic hemolysis induced by malignant hypertension - Case series and review of literature

Clinical Nephrology

Volumn 73, Issue 2, 2010, Pages 147-152

  Shavit, L ^a   Reinus, C ^a   Slotki, I ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Malignant hypertension; Microangiopathic hemolysis; Renal failure

Indexed keywords

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CEFUROXIME; CORTICOSTEROID; CREATININE; DIURETIC AGENT; FUROSEMIDE; LACTATE DEHYDROGENASE; LOSARTAN; METHYLPREDNISOLONE; RAMIPRIL;

ACUTE CORONARY SYNDROME; ADULT; ANEMIA; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORONARY ARTERY BYPASS GRAFT; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HUMAN; HUMAN TISSUE; HYPERPHOSPHATEMIA; HYPERTENSION RETINOPATHY; HYPOCALCEMIA; HYPOKALEMIA; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY FAILURE; MALE; MALIGNANT HYPERTENSION; NEPHROSCLEROSIS; PAPILLEDEMA; RETINA HEMORRHAGE; SINGLE DRUG DOSE; THORAX PAIN; THROMBOTIC THROMBOCYTOPENIC PURPURA; UPPER RESPIRATORY TRACT INFECTION;

ADULT; BIOPSY; BLOOD PRESSURE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION, RENAL; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX;

EID: 76649090941     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp73147     Document Type: Article

References (13)

1. Patel, R, Ansari, A, Grim, CE. Prognosis and predisposing factors for essential malignant hypertension in predominantly black patients. Am J Cardiol. 1990; 66: 868.
2. Sanerkin NG. Vascular lesions of malignant essential hypertension. J Pathol. 1971; 103: 177-184.
3. Jones DB. Arterial and glomerular lesions associated with severe hypertension. Light and electron microscopic studies. Lab Invest. 1974; 31: 303-313.
4. van den Born BJ, Honnebier UP, Koopmans RP et al. Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension. 2005; 45: 246-251.
5. Lawton WJ. The short-term course of renal function in malignant hypertensives with renal insufficiency. Clin Nephrol. 1982; 17: 277-283.
6. Yaqoob M, McClelland P, Ahmad R. Delayed recovery of renal function in patients with acute renal failure due to accelerated hypertension. Postgrad Med J. 1991; 67: 829-832.
7. Lip GY, Beevers M, Beevers DG. Does renal function improve after diagnosis of malignant phase hypertension? J Hypertens. 1997; 15: 1309-1315
8. van den Born BJ, Koopmans RP, van Montfrans GA. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension. Am J Hypertens. 2007; 20: 900-906.
9. van den Born BJ, van Montfrans GA, Uitterlinden AG, Zwinderman AH, Koopmans RP. The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. J Hypertens. 2007; 25: 2227-2233.
10. van den Born BJ, van der Hoeven NV, Groot E et al. Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension. Hypertension. 2008; 51: 862-866.
11. Zhang B, Xing C, Yu X et al. Renal thrombotic microangiopathies induced by severe hypertension. Hypertens Res. 2008; 31: 479-483.
12. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002; 347: 589-600.
13. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289: 2560-2572.